Blanket Purchase Agreement 36C25523A0024

Award Date 5/3/23
Last Date to Order 5/2/28
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 16 awarded a Blanket Purchase Agreement (BPA) to Accelerate Diagnostics, Inc., a for-profit manufacturer, to provide instrumentation, reagents, and test kits needed to perform rapid identification and antimicrobial susceptibility testing (ID/AST) of positive blood cultures. This BPA, valued at up to $550,500, enables the VA to acquire these critical diagnostic products and...
The U.S. Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of blood culture and antimicrobial susceptibility testing (AST)/identification (ID) reagents and diagnostic platforms. The contract has a total ceiling value of $2,462,079.76 and a period of performance through April 30, 2031, with no set-aside designation. The BPA includes two specific task orders, valued at $321,304.35 and...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) awarded a single-award Blanket Purchase Agreement (BPA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide Abbott ID NOW instruments and reagents. The $3,500,000 BPA, with a period of performance through September 2026, supports the VA's mission to provide veterans access to rapid point-of-care medical testing, particularly for respiratory illnesses like COVID-19 and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a Blanket Purchase Agreement to Cepheid for real-time polymerase chain reaction molecular microbiology testing services. The testing is for the detection of Methicillin-resistant Staphylococcus aureus on a cost-per-test basis. Under subsequent calls against the BPA, Cepheid has provided these services from various places of performance including Sunnyvale, CA, Tucson, AZ, and San...
The Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 15 (VISN 15) awarded a single-award Blanket Purchase Agreement (BPA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide a Polymerase Chain Reaction (PCR) Molecular Testing System. The BPA, valued at $919,854.50, has a period of performance through November 2, 2027 and does not include any set-aside provisions. Under this BPA, VISN 15 has issued multiple...
The U.S. Department of Veterans Affairs (VA) has awarded a single-award, indefinite delivery contract to Biomerieux Inc., a global leader in in vitro diagnostics, to provide bacterial identification and antibiotic susceptibility testing services to the VA's Veterans Integrated Service Network 2 (VISN 2). The contract, valued at a ceiling of $2,366,377.51, has an ultimate completion date of March 31, 2026 and does not utilize any set-aside designations. Under this IDC, Biomerieux Inc., through...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded Biomerieux Inc. a blanket purchase agreement to provide microbiological identification and susceptibility testing equipment, reagents, and supplies. The single award BPA has a potential value of $469,809.55 and period of performance through September 30, 2021. Three firm fixed price call contracts were issued against the BPA with values of $110,913.31, $37,582.90, and $24,882.40...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a single award Indefinite Delivery Contract to Biomerieux Inc. with a potential value of $7.4 million to provide identification, antimicrobial susceptibility testing, and matrix-assisted laser desorption/ionization clinical proteomics technology solutions. The original solicitation posted on January 18, 2023 sought these laboratory diagnostic testing equipment and services with a...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of automated microbiological blood culture testing equipment, reagents, and supplies. The BPA, with a total ceiling value of $2,295,562.32, was awarded to Biomerieux's Biomerieux, Inc. division, a foreign-owned, for-profit manufacturer of diagnostic solutions. The BPA, which does not have a set-aside designation, is intended to...
This Blanket Purchase Agreement (BPA) contract was awarded by the U.S. Department of Veterans Affairs (VA) to Biomerieux Inc., doing business as Vitek Systems, Inc. The contract covers the provision of blood culture incubation, identification, and antibiotic susceptibility testing (AST) services for the VA's VISN 19 network. Biomerieux Inc. is a global leader in in vitro diagnostics, specializing in advanced microbiological testing solutions for medical, food safety, and industrial applications....
  • 36C25523A0024
    Blanket Purchase Agreement
  • 3
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 awarded a single-award Blanket Purchase Agreement to Accelerate Diagnostics, Inc. to procure a Rapid ID/AST system for the St. Louis VA Medical Center. The BPA has a potential value of $286,930 and period of performance through May 2, 2028. A $57,386 firm fixed price call was placed against the BPA for the Rapid ID/AST system.

The Rapid ID/AST system will support the St. Louis VAMC in identifying and treating bacterial infections for veterans. Rapid pathogen identification and antibiotic susceptibility testing allow clinicians to prescribe targeted antibiotic therapy sooner. This tailored approach aims to improve health outcomes for patients while combating antibiotic resistance by reserving broad-spectrum drugs for cases where rapid diagnostics confirm their need. The St. Louis VAMC procurement of this diagnostic solution aligns with the VA's focus on providing quality, timely care for veterans through optimized treatment of common healthcare-associated infections.

Generated 1/4/24, 5:42 PM